Ovarian papillary serous tumors of low malignant potential (serous borderline tumors): A long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma

Cancer

Volumn 78, Issue 2, 1996, Pages 278-286

  Kennedy, Alexander W ^a   Hart, William R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

borderline tumors; exophytic ovarian surface tumor; invasive implants peritoneum; low malignant potential (LMP) tumors; malignant progression; microinvasive ovarian cancer; outcome; ovarian tumors; serous tumors

Indexed keywords

CHROMIUM PHOSPHATE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPLANT; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; MICROSCOPIC ANATOMY; OVARY TUMOR; PAPILLOMA; PREDICTION; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOMA, PAPILLARY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; STROMAL CELLS; TREATMENT OUTCOME;

EID: 0029684144     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960715)78:2<278::AID-CNCR14>3.0.CO;2-T     Document Type: Article

References (31)

1. Aure JC, Hoeg K, Kolstad P. Clinical and histologic studies of ovarian carcinoma. Obstet Gynecol 1971;37:1-9.
2. Russell P. The pathologic assessment of ovarian neoplasms. I. Introduction to the common "epithelial" tumors and analysis of benign "epithelial" tumors. Pathology 1979;11:5-26.
3. Kliman C, Rome RM, Fortune DW. Low malignant potential tumors of the ovary: a study of 76 cases. Obstet Gynecol 1986;63:338-44.
4. Massad LS Jr, Hunter VJ, Szpak CA, Clarke-Pearson DL, Creasman WT. Epithelial ovarian tumors of low malignant potential. Obstet Gynecol 1991;78:1027-32.
5. Biscotti CV, Hart WR. Peritoneal serous micropapillomatosis of low malignant potential (serous borderline tumors of the peritoneum): a clinicopathologic study of 17 cases. Am J Surg Pathol 1992;16:467-75.
6. Bell DA, Scully RE. Serous borderline tumors of the peritoneum. Am J Surg Pathol 1990;14:230-9.
7. Kurman RJ, Trimble CL. The behavior of serous tumors of low malignant potential: are they ever malignant? Int J Gynecol Pathol 1993;12:120-7.
8. Segal GH, Hart WR. Ovarian serous tumors of low malignant potential (serous borderline tumors): the relationship of exophytic surface tumor to peritoneal "implants." Am J Surg Pathol 1992;16:577-83.
9. Hart WR. Pathology of malignant and borderline (low malignant potential) epithelial tumors of ovary. In: Coppelson M, Monaghan JM, Morrow CP, Tattersall MRN, editors. Gynecologic oncology. Fundamental principles and clinical practice. 2nd edition. London: Churchill-Livingstone, 1992:863-87.
10. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990;21:397-403.
11. Tavassoli, FA. Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion). Mod Pathol 1988;1:407-14.
12. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors of the ovary. Histologic features and prognosis. Cancer 1988;62:2212-22.
13. International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in gynecologic cancer. Int J Gynaecol Obstet 1989;28:189-90.
14. Katzenstein AL, Mazur MT, Morgan TE, Kao MS. Proliferative serous tumors of the ovary. Histologic features and prognosis. Am J Surg Pathol 1978;2:339-55.
15. Gershenson DM, Silva EG. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 1990;65:578-85.
16. Leake JF, Currie JL, Rosenshein NB, Woodruff JD. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 1992;47:150-8.
17. Casey AC, Bell DA, Lage JM, Fuller AF, Nikrui N, Rice LW. Epithelial ovarian tumors of borderline malignancy: long term follow-up. Gynecol Oncol 1993;50:316-22.
18. Barnhill DR, Kurman RJ, Brady MF, Omura GA, Yordan E, Given FT, et al. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol 1995;13:2752-6.
19. Manchul LA, Simm J, Levin W, Fyles AW, Dembo AJ, Pringle JF, et al. Borderline epithelial ovarian tumors: a review of 81 cases with an assessment of the impact of treatment. Int J Radiat Oncol Biol Phys 1992;22:867-74.
20. Kaern J, Trope CG, Abeler VM. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. Cancer 1993;71:1810-20.
21. Tazelaar HD, Bostwick DG, Ballon SC, Hendrickson MR, Kempson RL. Conservative treatment of borderline ovarian tumors. Obstet Gynecol 1985;66:417-22.
22. Lim-Tan SK, Cajigas HB, Scully RE. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases. Obstet Gynecol 1988;72:775-80.
23. Fort MG, Pierce VK, Saigo PE, Hoskins WJ, Lewis JL Jr. Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1989; 32:269-72.
24. Barakat RR, Benjamin I, Lewis JL Jr, Saigo PE, Curtin JP, Hoskins WJ. Platinum based chemotherapy for advanced-stage ovarian carcinoma of low malignant potential. Gynecol Oncol 1995;59:390-3.
25. Hopkins MP, Kumar NB, Morley GW. An assessment of pathologic features and treatment modalities in ovarian tumors of low malignant potential. Obstet Gynecol 1987; 70:923-9.
26. Trope C, Kaern J, Vergote IB, Kristensen G, Abeler V. Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. Gynecol Oncol 1993;51:236-43.
27. Sutton GP, Bundy BN, Omura GA, Yordan EL, Beecham JB, Bonfiglio T. Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study). Gynecol Oncol 1991;41:230-3.
28. Nikrui N. Survey of clinical behavior of patients with border-line epithelial tumors of the ovary. Gynecol Oncol 1981; 12:107-19.
29. McCaughey WTE, Krik ME, Lester W, Dardick I. Peritoneal epithelial lesions associated with proliferative serous tumors of ovary. Histopathology 1983;8:195-208.
30. Michael H, Roth LM. Invasive and noninvasive implants in ovarian serous tumors of low malignant potential. Cancer 1986;57:1240-7.
31. Leake JF, Rader JS, Woodruff JD, Rosenshein NB. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1991; 42:124-30.